nelf-e antibody (Millipore)
Structured Review
Nelf E Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nelf+e/anti+nelf+e/pm37117180-412-0-2
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis. Article Snippet: Article Title: NELF ‐E is recruited to DNA double‐strand break sites to promote transcriptional repression and repair Article Snippet: Clones that showed expression of EGFP‐NELF‐E only after the addition of Article Title: Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis Article Snippet: The slides were then blocked in 10% goat serum for 30 min. Article Title: Integrator complex regulates NELF-mediated RNA polymerase II pause/release and processivity at coding genes Article Snippet: An amount of 10 μg of Article Title: Architecture and RNA binding of the human negative elongation factor Article Snippet: 293FT cells were maintained in DMEM (Gibco) with 10% FBS and Glutamax. Article Title: Architecture and RNA binding of the human negative elongation factor Article Snippet: Cells were routinely checked for mycoplasma contamination using the PlasmoTest Mycoplasma Detection Kit (InvivoGen, 12K06-MM). Article Title: Striatal NELF-mediated RNA polymerase II stalling controls L-dopa induced dyskinesia. Article Snippet: Contents lists available at ScienceDirect Neurobiology of Disease j ourna l homepage: www.e lsev ie r .com/ locate /ynbd i Striatal NELF-mediated RNA polymerase II stalling controls L-dopa induced dyskinesia Matthieu F. Bastide, Simone Bido, Nathalie Duteil, Erwan Bézard ⁎ a Univ. de Bordeaux, Institut des Maladies Neurodégénératives,UMR 5293,33000 Bordeaux,France b CNRS,Institut des Maladies Neurodégénératives,UMR 5293,33000 Bordeaux,France ⁎ Corresponding author at: Institut des Maladies Neu Bordeaux,UMR 5293, Bât 3B 1er étage, 146 rue Léo Sai France.. E-mail address: erwan.bezard@u-bordeaux.fr (E. Béza Available online on ScienceDirect (www.sciencedir http://dx.doi.org/10.1016/j.nbd.2015.10.013 0969-9961/© 2015 Elsevier Inc. All rights reserved. a b s t r a c t a r t i c l e i n f o Article history: Received 17 September 2015 Revised 7 October 2015 Accepted 14 October 2015 Available online 19 October 2015 Keywords: Immediate-early genes Transcription Stalling Parkinson's disease Rat model Long-term L-3,4-dihydroxyphenylalanine (L-Dopa) treatment in Parkinson's disease leads to involuntary movements called dyskinesia, notably through an overexpression of immediate-early genes (IEG).. Their rapid transcription involves the stalling of RNA polymerase II on IEG promoters, a mechanism that critically depends on the presence of the negative elongation factor (NELF) protein complex. Chromatin Immunoprecipitation:Article Title: Pausing of RNA polymerase II Regulates Mammalian Developmental Potential Through Control of Signaling Networks Article Snippet: .. ChIP was performed as previously described ( Gilchrist et al., 2010 ) using antibodies targeting the |
